Related Experiment Video
Updated: Jun 25, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Topical tacrolimus for repigmentation of vitiligo
Pearl E Grimes1, Teresa Soriano, Marlene T Dytoc
1Vitiligo and Pigmentation Institute of Southern California, Los Angeles, CA, USA. pegrimesmd@earthlink.net
Journal of the American Academy of Dermatology
|October 26, 2002
Summary
Tacrolimus ointment shows promise for treating generalized vitiligo, with 5 out of 6 patients experiencing significant skin repigmentation. This study suggests it may be an effective and safe therapeutic option for vitiligo patients.
Area of Science:
- Dermatology
- Immunology
Background:
- Vitiligo is a chronic autoimmune condition characterized by depigmentation.
- Current treatments for generalized vitiligo have variable efficacy and potential side effects.
Purpose of the Study:
- To evaluate the efficacy and safety of topical tacrolimus ointment in patients with generalized vitiligo.
Main Methods:
- A series of 6 patients with generalized vitiligo were treated with tacrolimus ointment.
- The study was noncontrolled and nonblinded.
Main Results:
- Five out of six patients achieved moderate to excellent repigmentation.
- Tacrolimus ointment was generally well-tolerated by the patients.
Conclusions:
- Topical tacrolimus ointment may be an effective and safe treatment for generalized vitiligo.
- Further controlled studies are warranted to confirm these findings.
